Arterial Interventions and Peripheral Arterial Disease (PAD)

Session: Educational Exhibit Presentations - Station 1: Arterial Interventions and Peripheral Arterial Disease (PAD)

An Update on Devices Used in Vascular Disease

Monday, March 6, 2023

5:40 PM – 5:45 PM

Location: Phoenix Convention Center, North Ballroom 120ABC, Poster Hall

Abstract Presenter(s)

MG

Muhammad S. Ghauri, MS

Medical Student
California University of Science and Medicine

Disclosure(s): No financial relationships to disclose

Author/Co-author(s)

TS

Talha Shabbir, MS

Medical Student
California University of Science and Medicine
AA

Ahmad Alach, BS

Medical Student
Kaiser Permanente Bernard J. Tyson School of Medicine
Caleb F. Solivio, BS (he/him/his)

Medical Student
California University of Science and Medicine
AB

Alok Bhatt, MD

Assistant Program Director of Vascular and Interventional Integrated Residency
Kaiser Permanente Los Angeles
Kartik Kansagra, MD

Vascular and Interventional Physician
KP VISLA
GV

Geogy Vatakencherry, MD, FSVM,FSIR

Program Director of Vascular and Interventional Integrated Residency
Kaiser Permanente physician

Disclosure(s):

Muhammad S. Ghauri, MS: No financial relationships to disclose

Caleb F. Solivio, BS: No financial relationships to disclose

Kartik Kansagra, MD: No financial relationships to disclose

Geogy Vatakencherry, MD FSIR: No financial relationships to disclose

Learning Objectives: 1. Explore cutting-edge vascular devices recently approved by the FDA within the last year
2. Highlight the advantages of these devices and how they are used to target specific vascular diseases
3. Identify the limitations of current vascular devices and areas of future improvement

Background: Vascular disease (VD) comprises various pathologies of the circulatory system affecting nearly 200 million people globally leading to billions of dollars in healthcare spending. The insidious nature of this disease explains why most patients remain asymptomatic until complications such as claudication, myocardial infarction, or stroke ensues. We have seen a trend towards increasingly less invasive modalities that leverage structural and pharmacological innovation to manage these complex pathologies. In this educational exhibit, we will be reviewing the most recent FDA-approved devices used to treat VD.

Clinical Findings/Procedure Details: In 2022, we saw advancements in coronary and cerebral stenting utilizing new balloon and stent technology, novel delivery of pharmacologic adjuncts, structural innovations for aortic valve repair, and improved catheter ablation devices to treat abnormal heart rhythms. The FDA has approved nine devices used in endovascular repair (GORE TAG), cerebrovascular stenting (NeVA VS), coronary stenting (BIOFREEDOM/SLENDER), carotid artery stenting (ENROUTE), balloon angioplasty (Stellarex), aneurysm repair (Thoraflex Hybrid), catheter ablation (TactiCath), and aortic valve repair (Portico). This exhibit will highlight the indications, advantages, disadvantages, and future direction for utilizing these devices in the sphere of VIR.

Conclusion and/or Teaching Points: As the incidence of VD increases, devices used in vascular interventional radiology are continually improving. In this exhibit, the learner will gain an overview of the current techniques and procedures utilized in treating vascular disease. The limitations discovered from the implementation of these modalities are uncovering new avenues of investigation. Overall, understanding these cutting-edge devices will improve the management of VD, and therefore is important for all VIR.